HIGHLIGHTS
- who: Julie Bernardor from the American University of Beirut, Lebanon Center, Russia have published the research: Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience, in the Journal: (JOURNAL)
- what: The authors aimed to retrospectively report the French experience of cinacalcet in pediatric PHPT. The authors observed a significant decrease of calcium levels after 1 month of therapy that was sustained until the last follow-up; no hypocalcemia was reported. The aim for physicians was to obtain acceptable calcium levels allowing to obtain optimal growth with adequate nutritional calcium intake for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.